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Redo-ablations of atrial fibrillation: procedural characteristics depending
on the choice of cryoenergy or radiofrequency ablation as the first line
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Introduction Pulmonary vein (PV) isolation has become a cornerstone
therapy for symptomatic paroxysmal AF refractory to anti-arrhythmic drugs.
Nowadays, the most common energies used to achieve PV isolation are
cryoenergy and radiofrequency (RF). However, approximately one third of the
patients have recurrences, mainly due to PV reconnections. 
Little is known about the characteristics of the redo procedure, depending
on the choice of the initial energy.
Methods Patients referred to our center for a RF redo ablation procedure
of symptomatic paroxysmal AF (PxAF) between 2010 and 2014 were retro-
spectively enrolled. 
Demographic data and characteristics of the initial ablation, i.e. cryoenergy
or RF ablations, were collected. Number and location of PV gaps, and redo
characteristics were reviewed.
Results 74 patients scheduled for a redo ablation of AF were included, 38
and 36 using RF or cryoablation for the first procedure, respectively. For the
initial ablation, procedural and fluoroscopy times were significantly shorter
when using cryoenergy (147.8±52.6 vs. 226.6±64.3 min, p<0.001, and
37.0±17.7 vs. 50.8±22.7 min, p=0.005, respectively). Overall, an identical
number of gaps were found during redo procedures of cryo and RF ablations.
However, a significantly higher number of gaps were located in the right supe-
rior PV (RSPV) for patient first ablated with RF (0.9±1.0 vs. 0.5±0.9,
p=0.009). The location of gaps was different, predominantly found in the ante-
rior and superior parts of the left superior PV (LSPV), the anterior and inferior
part of the left inferior PV (LIPV), the superior part of the right superior PV
(RSPV), and in the postero-inferior part of the right inferior PV (RIPV) when
using RF as the initial energy. For patient first ablated with cryoenergy, gaps
were predominantly found in the anterior part of the left PV, evenly distrib-
uted in the RSPV, and in the postero-inferior part of the RIPV. Although not
significant, redo procedures of cryoablations were slightly shorter and needed
less RF duration times to achieve PV isolation (160.0±55.7 vs. 175.7±59.1
min, p=NS, and 954.1±796.7 vs. 1476.7±1269.6, p=NS). 
Conclusion During redo procedures, gaps location pattern is different for
patients first ablated with cryo or RF energy, and RSPV reconnections occur
more frequently after RF ablation, probably due to poor contact in this region.
Procedural characteristics of the redo ablation are similar.
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Introduction De novo atrial fibrillation (AF) is common in the acute coro-
nary syndrome (ACS), but most patients (P) are discharged in sinus rhythm
(SR). The recurrence of arrhythmia in follow-up (FU) remains unknown and
its undervaluation may have prognostic impact. 
Aim To characterize a population with ACS and de novo AF and determine
its prognostic impact. 
To evaluate the recurrence of AF and the incidence of ischemic stroke/sys-
temic embolism in FU. 
Methods We analyzed 2383 P consecutivelly admitted with ACS and with
a minimum of 180 days FU. 
De novo AF has been defined as AF first detected on admission or during
hospitalization. 
Results It has been observed de novo AF in 199 P (8.4%), the majority
being male (70.4%). These patients were significantly older (p<0.001) and had
higher HTA prevalence (p<0.001. 
The echocardiographic evaluation showed a higher prevalence of mitral
insufficiency (p<0.001) and left ventricular ejection fraction <40% (p<0.001).
These P developed more frequently heart failure (p<0.001) and stroke
(p=0.001) during hospitalization.
Abstract 0463 – Figure: Characteristics of the population
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Gender (male) 64 (60%) 79 (75%) 0.03
AF history (years) 4.2±3 3.8±3 0.34
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Redo procedure 41 (37%) 10 (9.4%) <0.01
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Abstract 0029 – Figure: Localization of gaps, during the redo procedure
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The in-hospital mortality (9.5% vs 3.3%, p<0.001) and at 6 months (15.6%
vs 6.6%, p<0.001) were also higher, however, the presence of de novo AF was
not an independent predictor of these events. Most P were discharged in SR
(n=134) and without anticoagulant therapy (n=117). 
95 patients with de novo AF were followed for a median period of
690 days and it was observed the occurrence of ischemic stroke/systemic
embolism in 9 P (9.5%), but only one was under oral anticoagulation. 
AF occurred in 37.5% of P that were in SR on discharge. 
Conclusion The presence of de novo AF was associated with increased
risk of adverse events, although it may constitute only a marker of severity. 
We observed recurrence of AF in a considerable sample, which denotes the
need for appropriate evaluation of thromboembolic risk of these P.
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Background Radiofrequency catheter ablation (RFCA) is increasingly used
in the management of ventricular tachycardia (VT) in arrhythmogenic right
ventricular dysplasia/cardiomyopathy (ARVC/D) but it is associated with a
high level of recurrences.
Objective To determine predictors associated with VT recurrence after
RFCA in ARVC/D.
Methods This study included 85 consecutive patients referred to the Pitié
Salpêtrière Hospital (Paris, France) who underwent a total of 149 RFCA pro-
cedures between 2000 and 2010. Predictors of recurrence of VT following
RFCA were assessed by Cox regression.
Results The mean age of the cohort was 36±13 years, 74 (87.1%) were
men and 80 (95.2%) were proband. 70 (83.3%) experienced spontaneous VT
before diagnosis. 30 (58.8%) patients required ≥2 procedures. In 13 (10.7%)
patients, RFCA was performed through epicardial access. Over a mean
follow- up of 114±60 months, the overall freedom from VT of the 149 proce-
dures was 79%, and 56%, at 1 and 5 years, respectively. The presence of an
epsilon wave and of right ventricular (RV) dysfunction (defined by RV angi-
ography ejection fraction <40% or right area fractional change <35% by TTE)
were associated with higher level of recurrences on multivariate analysis. The
cumulative freedom from VT (Figure) in patients without RV dysfunction nor
epsilon wave was 86% at 1 and 5 years, which was significantly longer than
those without (76% and 47% respectively, P=0.003). 
Conclusion Absence of RV dysfunction or of an epsilon wave are strongly
associated with higher success after VT RFA in ARVC/D. Patients without
those risk factors should therefore be considered as good candidates for VT
ablation.
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Background Atrial arrhythmias (AA) are observed frequently early after
lung transplant and also late after the surgery. Several predictive factors of
post-operative AA after lung transplant have been already identified whereas
those of late AA are still not known. Whether AA after lung transplant
impacts mortality and the optimal strategy of rhythm management are still
debated.
The Purpose of the study was to assess in a large cohort of lung trans-
planted patients the incidence of AA early and late after surgery, their predic-
tive factors and their impact on mortality. 
Methods and results We included 271 consecutive patients single or
double lung-transplanted over a 9-years period in a large French center. We
collected baseline clinical, surgery and post-operative data. The follow-up was
2,9±2,4 years. 33% patients developed post-operative AA. Age (HR=2,35; CI
[1,31-4,24]) and chronic obstructive pulmonary disease (HR=1,028; CI [1,12-
4,03]) were independant predictive factors of post-operative AA. Late AA
occurred 2,2±2,7 years after transplant in 8.8% of the patients. Systolic pul-
monary arterial pressure was the only independent predictive factor of late AA
(HR=1,028; CI [1,001; 1,056]). Double lung transplant was associated with
long term freedom from AF compared with single transplant (p=0,05) whereas
the Kaplan-Meier curve for the development of late atrial flutter was similar
in single and double lung transplant. Early and late AA after surgery showed
no impact on mortality. Bilateral lung transplant was associated with a better
survival.
Conclusion Post-operative AA after lung transplantation are common with
good outcome and contrast with the low occurrence of late organized AA.
Double lung transplantation protects against AF but not AFL. Underlying
electrophysiological mechanisms may explain these observations. Predictive
factors of early and late AA after transplantation are different. Nevertheless
these AA do not impact mortality after lung transplant (figure next page). 
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Abstract 0523 – Figure: Survival analysis
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